Tag: medical news

XDR Shigella Spreads Beyond High-Risk Groups in LA County
School Illness

XDR Shigella Spreads Beyond High-Risk Groups in LA County

LAC DPH reports a rise in extensively drug-resistant Shigella cases in 2024, with 68 cases...

13/11/2026
Measles Cases Surge, Three States Report Fatalities
Growth Charts

Measles Cases Surge, Three States Report Fatalities

Measles cases surge with 5,182 infections and three fatalities reported across multiple U.S. states, according...

07/11/2026
Labcorp introduces reflex testing for hepatitis D
Growth Charts

Labcorp introduces reflex testing for hepatitis D

Labcorp's new hepatitis D testing reflex option aims to close the diagnostic gap, targeting U.S....

05/11/2026
FDA Approves Jaypirca for Untreated CLL and SLL
Germ Control

FDA Approves Jaypirca for Untreated CLL and SLL

The FDA approves Jaypirca for previously untreated CLL and SLL without del(17p), showing improved outcomes...

24/10/2026
Canadian Study Finds Physicians with Disabilities, Urges Accessibility
Growth Charts

Canadian Study Finds Physicians with Disabilities, Urges Accessibility

A Canadian study reveals 5% of physicians report disabilities 'always or often,' urging improved workplace...

13/10/2026
Gene linked to fat storage may raise anorexia risk
School Illness

Gene linked to fat storage may raise anorexia risk

Scientists found a gene linked to fat storage that may raise anorexia risk. The study...

08/10/2026
Genetic testing aids epilepsy diagnosis in children
Lunch Nutrition

Genetic testing aids epilepsy diagnosis in children

Genetic testing aids epilepsy diagnosis in children with seizures and developmental delays, offering new insights...

17/09/2026
Eight New Muscular Dystrophy Therapies Show Promise
Lunch Nutrition

Eight New Muscular Dystrophy Therapies Show Promise

Eight new muscular dystrophy therapies show promise in targeting disease mechanisms, moving beyond traditional care...

14/09/2026
FDA fast-tracks first drug for MOGAD
Lunch Nutrition

FDA fast-tracks first drug for MOGAD

The FDA fast-tracks satralizumab for MOGAD, a rare autoimmune disease. This decision could make it...

11/09/2026
Gene therapy shows promise for seizure patients
Growth Charts

Gene therapy shows promise for seizure patients

Gene therapy shows promise for seizure patients with sustained reductions in seizure frequency and improved...

10/09/2026